Mossad the Israel intelligence agency has brought China's coronavirus vaccine for 'study'has been reported by the local media. After a Regulatory approval Israel will begin human trials for a potential COVID-19 vaccine developed by a research institute will be overseen by the Defence Ministry on November 1. The ultimate aim of the purchase is to be a study of the Chinese compound and further exploring vaccination options, says the Ministry.
Israelis launch protest against PM Benjamin, demanding resignation
A senior health ministry official said ''There are several diplomatic efforts going on behind the scenes. We are trying everything we can to ensure Israeli citizens have access to a vaccine as soon as possible". On the other hand, the Israel Institute for Biological Research (IIBR) began animal trials for its "BriLife" vaccine in March and is taking next stage as the Health Ministry and an oversight committee gives green signal. 8 volunteers aged between 18 and 55 will be monitored for three weeks and virus antibodies development will be monitored, the ministry said in a statement. A second phase, expected to begin in December, will involve 960 people above 18.
Israel joined the race of Corona Vaccine
Third stage large-scale phase with 30,000 volunteers has been planned for April/May. Upon successful testing, the vaccine may then be approved for mass use. The vaccine was tested well on a number of animal models and the IIBR has produced more than 25,000 doses for the first and second phases of the clinical trials. Israel with 9 million population is relaxing the second nationwide coronavirus lockdown after a steady decline in the rate of daily infections.